Add to ORKGA New Source of Stem Cells House Call: Complementary and Alternative Medicine: Sorting through the Choices DiaLog: Risks and Benefits of Phase I Oncology Trials, by Razelle Kurzrock, MD, Professor, Division of Cancer Medicine Phase I Program, and Robert S. Benjamin, MD, Professor, Department of Sarcoma Medical Oncologyhttps://openworks.mdanderson.org/oncolog/1152/thumbnail.jp
Allogeneic bone marrow transplantations (BMT) from HLA-matched siblings have been successfully used ...
Allogeneic stem cell transplantation is an ac-cepted treatment modality for selected malignant and n...
Current therapeutic uses of umbilical cord blood stem cells and the promise of these cells for the t...
A New Source of Stem Cells House Call: Complementary and Alternative Medicine: Sorting through the C...
Advances Allow Expanded Use of Allogeneic Stem Cell Transplantation Use of Umbilical Cord Blood Expa...
Advances in Stem Cell Transplantation More Is Better, But How Much Is Enough? House Call: Save a Lif...
Not all blood cells are created equal. Some are born, carry out their appointed tasks-red blood cell...
Sentinel Lymph Node Biopsy: Detection of Micrometastases Leads to More Precise Staging of Breast and...
“Sickle cell is now a part of my past. One year after my transplant, I was pronounced cured. Stem ce...
Background Umbilical cord blood is a potential vast source of primitive hematopoietic stem and proge...
Umbilical cord transplants have emerged as an important therapeutic option for patients with leukemi...
The number of hematopoietic stem cells (HSCs) collected in cord blood (CB) at the birth of a baby is...
Objectives: To review information on cord blood banking and transplantation with respect to the aut...
Allogeneic hematopoietic cell transplantation (HCT) is an important therapeutic option for a variety...
Genetic testing: a new paradigm for medullary thyroid carcinoma Bone marrow transplantation now avai...
Allogeneic bone marrow transplantations (BMT) from HLA-matched siblings have been successfully used ...
Allogeneic stem cell transplantation is an ac-cepted treatment modality for selected malignant and n...
Current therapeutic uses of umbilical cord blood stem cells and the promise of these cells for the t...
A New Source of Stem Cells House Call: Complementary and Alternative Medicine: Sorting through the C...
Advances Allow Expanded Use of Allogeneic Stem Cell Transplantation Use of Umbilical Cord Blood Expa...
Advances in Stem Cell Transplantation More Is Better, But How Much Is Enough? House Call: Save a Lif...
Not all blood cells are created equal. Some are born, carry out their appointed tasks-red blood cell...
Sentinel Lymph Node Biopsy: Detection of Micrometastases Leads to More Precise Staging of Breast and...
“Sickle cell is now a part of my past. One year after my transplant, I was pronounced cured. Stem ce...
Background Umbilical cord blood is a potential vast source of primitive hematopoietic stem and proge...
Umbilical cord transplants have emerged as an important therapeutic option for patients with leukemi...
The number of hematopoietic stem cells (HSCs) collected in cord blood (CB) at the birth of a baby is...
Objectives: To review information on cord blood banking and transplantation with respect to the aut...
Allogeneic hematopoietic cell transplantation (HCT) is an important therapeutic option for a variety...
Genetic testing: a new paradigm for medullary thyroid carcinoma Bone marrow transplantation now avai...
Allogeneic bone marrow transplantations (BMT) from HLA-matched siblings have been successfully used ...
Allogeneic stem cell transplantation is an ac-cepted treatment modality for selected malignant and n...
Current therapeutic uses of umbilical cord blood stem cells and the promise of these cells for the t...